The Korean journal of internal medicine

  • 제32권6호
  • /
  • Pages.1037-1044
  • /
  • 2017
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Epidemiological trend of pulmonary thromboembolism at a tertiary hospital in Korea

  • Park, Tae Yun (Department of Internal Medicine, Chung-Ang University Hospital) ;
  • Jung, Jae-Woo (Department of Internal Medicine, Chung-Ang University Hospital) ;
  • Choi, Jae Chol (Department of Internal Medicine, Chung-Ang University Hospital) ;
  • Shin, Jong Wook (Department of Internal Medicine, Chung-Ang University Hospital) ;
  • Kim, Jae Yeol (Department of Internal Medicine, Chung-Ang University Hospital) ;
  • Choi, Byoung Whui (Department of Internal Medicine, Chung-Ang University Hospital) ;
  • Park, In Won (Department of Internal Medicine, Chung-Ang University Hospital)
  • 투고 : 2016.07.30
  • 심사 : 2016.11.07
  • 발행 : 2017.11.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: Despite increasing interest in pulmonary thromboembolism (PTE), data on recent trends in PTE incidence are limited. This study evaluated the recent incidence rate of PTE. Methods: We performed a retrospective chart review of patients with PTE admitted to Chung-Ang University Hospital during the 10-year period from 2006 to 2015. Age-standardized incidence and mortality rates were calculated by the direct method per 100,000 populations. To analyze the trend of risk factor, we also calculated the proportions of cancer, major operation, and recent major fracture over that time. Results: Total crude incidence rate of PTE per 100,000 was 229.36 and the age-sex adjusted standardized incidence rate was 151.28 (95% confidence interval [CI], 127.88 to 177.10). The incidence rate have been significantly increased 1.083 times annually from 2006 (105.96 per 100,000) to 2015 (320.02 per 100,000) (95% CI, 1.049 to 1.118; p < 0.001). These incidences also increased annually in age group of 35 to 54, 55 to 74, and ${\geq}$ 75 years, and in both males (odds ratio [OR], 1.071; 95% CI, 1.019 to 1.127; p = 0.007) and females (OR, 1.091; 95% CI, 1.047 to 1.136; p < 0.001). Cancer accounted for most of the increase from 20.0% at 2006 to 2007 to 42.8% at 2014 to 2015 (OR, 1.154; 95% CI, 1.074 to 1.240; p < 0.001), while the proportions of recent fracture and major operation remained constant. Conclusions: The incidence of pulmonary embolism has gradually increased over the 10 years. The increase of PTE incidence was mainly due to increased proportion of cancer patients.

키워드

참고문헌

  1. Stein PD, Beemath A, Olson RE. Trends in the incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients. Am J Cardiol 2005;95:1525-1526. https://doi.org/10.1016/j.amjcard.2005.02.030
  2. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000;83:657-660. https://doi.org/10.1055/s-0037-1613887
  3. Ho WK, Hankey GJ, Eikelboom JW. The incidence of venous thromboembolism: a prospective, community-based study in Perth, Western Australia. Med J Aust 2008;189:144-147.
  4. Mahan CE, Borrego ME, Woersching AL, et al. Venous thromboembolism: annualized United States models for total, hospital-acquired and preventable costs utilizing long-term attack rates. Thromb Haemost 2012;108:291-302. https://doi.org/10.1160/TH12-03-0162
  5. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012;379:1835-1846. https://doi.org/10.1016/S0140-6736(11)61904-1
  6. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med 2010;363:266-274. https://doi.org/10.1056/NEJMra0907731
  7. Kroger K, Kupper-Nybelen J, Moerchel C, Moysidis T, Kienitz C, Schubert I. Prevalence and economic burden of pulmonary embolism in Germany. Vasc Med 2012;17:303-309. https://doi.org/10.1177/1358863X12449363
  8. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 1991;151:933-938. https://doi.org/10.1001/archinte.1991.00400050081016
  9. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population- based study. Arch Intern Med 1998;158:585-593. https://doi.org/10.1001/archinte.158.6.585
  10. Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2011;9:85-91. https://doi.org/10.1111/j.1538-7836.2010.04108.x
  11. Choi WI, Lee MY, Oh D, Rho BH, Hales CA. Estimated incidence of acute pulmonary embolism in a Korean hospital. Clin Appl Thromb Hemost 2011;17:297-301. https://doi.org/10.1177/1076029610368669
  12. Kim DS. Introduction: health of the health care system in Korea. Soc Work Public Health 2010;25:127-141. https://doi.org/10.1080/19371910903070333
  13. Stein PD, Huang Hl, Afzal A, Noor HA. Incidence of acute pulmonary embolism in a general hospital: relation to age, sex, and race. Chest 1999;116:909-913. https://doi.org/10.1378/chest.116.4.909
  14. Sakuma M, Takahashi T, Demachi J, et al. Epidemiology of pulmonary embolism in Japan. In: Shirato K, ed. Venous Thromboembolism. Tokyo: Springer, 2005:3-12.
  15. DeMonaco NA, Dang Q, Kapoor WN, Ragni MV. Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med 2008;121:611-617. https://doi.org/10.1016/j.amjmed.2008.02.035
  16. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 2011;171:831-837.
  17. Schissler AJ, Rozenshtein A, Schluger NW, Einstein AJ. National trends in emergency room diagnosis of pulmonary embolism, 2001-2010: a cross-sectional study. Respir Res 2015;16:44. https://doi.org/10.1186/s12931-015-0203-9
  18. Shen VS, Pollak EW. Fatal pulmonary embolism in cancer patients: is heparin prophylaxis justified? South Med J 1980;73:841-843. https://doi.org/10.1097/00007611-198007000-00005
  19. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010;19:1893-1907. https://doi.org/10.1158/1055-9965.EPI-10-0437
  20. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1-14. https://doi.org/10.4143/crt.2013.45.1.1
  21. Abdel-Razeq HN, Mansour AH, Ismael YM. Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome: a comprehensive cancer center experience. Vasc Health Risk Manag 2011;7:153-158. https://doi.org/10.2147/VHRM.S17947
  22. Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007;25:5490-5505. https://doi.org/10.1200/JCO.2007.14.1283
  23. Hardwick ME, Colwell CW Jr. Advances in DVT prophylaxis and management in major orthopaedic surgery. Surg Technol Int 2004;12:265-268.
  24. Keller K, Beule J, Coldewey M, Geyer M, Balzer JO, Dippold W. The risk factor age in normotensive patients with pulmonary embolism: effectiveness of age in predicting submassive pulmonary embolism, cardiac injury, right ventricular dysfunction and elevated systolic pulmonary artery pressure in normotensive pulmonary embolism patients. Exp Gerontol 2015;69:116-121. https://doi.org/10.1016/j.exger.2015.05.007

피인용 문헌

  1. Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants vol.34, pp.6, 2017, https://doi.org/10.3346/jkms.2019.34.e52
  2. Chronic venous insufficiency and varicose veins of the lower extremities vol.34, pp.2, 2019, https://doi.org/10.3904/kjim.2018.230